One of the newest marijuana listings on a senior US exchange has started receiving analyst coverage from leading financial institutions.
Vivien Azer, managing director and senior research analyst at Cowen, offered the most bullish outlook on the marijuana company. The analyst gave a “buy” rating and assigned a US$20 price target.
Azer is confident that Sundial Growers will be able to deliver results for its craft product at scale.
Shares of the cannabis grower opened on Monday at a price of US$9.54. As of 3:28 p.m. EDT, the company was trading at US$9.50, representing a drop in value of 1.45 percent.
Canadian analysts were more reserved with their predictions for the marijuana company.
CIBC Capital Markets equity research analyst John Zamparo assigned the company a 12 to 18 month price target of US$11. The analyst highlighted some of the perks for Sundial Growers but, ultimately, issued a “neutral” rating.
“Execution risk exists across the cannabis space but is particularly relevant at Sundial, in our view, as the company has little by way of a performance track record,” Zamparo wrote in his research note.
The analyst expressed reservations about the company’s ability to differentiate its products enough to execute in North America and the UK.
Tamy Chen, equity research analyst with BMO Capital Markets, initiated her coverage with a price target of US$11.
The marijuana company has operating facilities in Canada and the UK. Sundial Growers reached the NASDAQ in August by way of an initial public offering (IPO) of 10 million shares.
The company released its shares at a price of US$13 each. Following the completion of its IPO, Sundial Growers gained gross proceeds of US$143 million. It has been approved for two facilities in Alberta.
According to the company’s Q2 2019 financial report, its purpose-built modular facility in Olds, Alberta, has produced over 150 harvests in 2019, averaging yields of over 50 grams a square foot. The company reported C$20.3 million in revenue for Q2 2019, which Zamparo called impressive in his note.
In August, MarketWatch reported that Sundial Growers was facing the return of half of a wholesale order of marijuana product sold to Zenabis Global (TSX:ZENA). According to unnamed sources, Zenabis said the product from Sundial Growers was of low quality. MarketWatch states:
In its own June-quarter report the same morning, Canadian cannabis company Zenabis Global disclosed that it had returned a half ton of pot and terminated its agreement to buy weed from a “third party” that it did not name. People familiar with the matter say that party was Sundial, and Zenabis returned the cannabis because the pot was of poor quality and contained bits of rubber, among other issues.
Following the report from MarketWatch, the company issued a statement indicating it did not notice any impact on its Q2 earnings or its upcoming Q3 report.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
The product will include polyphenols known to have significant health benefits.